IPO Profile: Akebia Therapeutics Inc
Kearny Venture Partners, Novartis Bioventures, Novo A/S, Triathlon Medical Ventures and Venture Investors collectively own 8.4 million shares valued at $143.45 million at the IPO price.
11 April 2014•1 min read
Kearny Venture Partners, Novartis Bioventures, Novo A/S, Triathlon Medical Ventures and Venture Investors collectively own 8.4 million shares valued at $143.45 million at the IPO price.
